Cargando…
RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC
BACKGROUND: The combination of sonodynamic therapy and oxygenation strategy is widely used in cancer treatment. However, due to the complexity, heterogeneity and irreversible hypoxic environment produced by hepatocellular carcinoma (HCC) tissues, oxygen-enhancing sonodynamic therapy (SDT) has failed...
Autores principales: | Chen, Yichi, Shang, Haitao, Wang, Chunyue, Zeng, Jiaqi, Zhang, Shentao, Wu, Bolin, Cheng, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752973/ https://www.ncbi.nlm.nih.gov/pubmed/35027829 http://dx.doi.org/10.2147/IJN.S343361 |
Ejemplares similares
-
RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC
por: Shang, Haitao, et al.
Publicado: (2022) -
Quantitative Proteomics Analysis of FFPE Tumor Samples Reveals the Influences of NET-1 siRNA Nanoparticles and Sonodynamic Therapy on Tetraspanin Protein Involved in HCC
por: Wu, Bolin, et al.
Publicado: (2021) -
Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma
por: Tian, Huimin, et al.
Publicado: (2023) -
IR-820@NBs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy
por: Wang, Xiaodong, et al.
Publicado: (2023) -
Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma
por: Wu, Bolin, et al.
Publicado: (2021)